Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.0001 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
100000
Market Cap
0.04M

Momentum Score

…

Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. was incorporated in 2006 and is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Emergent Health Corp is an OTC Pink-listed company; public disclosures and regulatory filings are limited, so its core products, revenue sources, and operational footprint are unclear. Long-term growth would depend on establishing commercial traction, securing regulatory approvals where relevant, and accessing reliable financing or strategic partnerships, and investors may find potential upside if management delivers clearer disclosures and measurable progress.

Primary risks include extreme share illiquidity, frequent financing-related dilution, operational and regulatory uncertainty common to small OTC issuers, heightened share-price volatility, and the risk of delisting or weak corporate governance.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
0.12M
Revenue Per Share
0.00
Gross Profit TTM
0.08M
Debt / Equity
-1.02
ROE
-164.17%
Net Debt
2.46M
ROCE
59.85%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -1.63M -2.11M -0.00M -0.00M -0.07M
Net income -1.63M -2.11M -0.00M -0.00M -0.07M
Selling general administrative - - 0.00M 0.00M -
Selling and marketing expenses - - 0.00M 0.00M -
Gross profit 1.04M 0.13M 0.00M 0.00M 0.13M
Ebit -1.41M -1.75M -0.00M -0.00M -0.06M
Ebitda -1.39M -1.73M -0.00M -0.00M -0.05M
Depreciation and amortization 0.02M 0.02M 0.00M 0.00M 0.01M
Operating income -1.41M -1.76M -0.00M -0.00M -0.06M
Other operating expenses 3.04M 2.33M 0.00M 0.00M 0.24M
Interest expense 0.22M 0.36M - - 0.01M
Income tax expense 0.00M -0.00M -0.00M -0.00M -0.00M
Total revenue 1.64M 0.57M 0.00M 0.00M 0.18M
Total operating expenses 2.45M 1.88M 0.00M 0.00M 0.19M
Cost of revenue 0.60M 0.45M 0.00M 0.00M 0.05M
Total other income expense net -0.22M -0.35M -0.00M -0.00M -0.01M
Net income applicable to common shares - - -0.29M -0.08M -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 0.53M 0.79M 0.00M 0.00M 0.40M
Intangible assets 0.09M 0.11M 0.00M 0.00M -
Other current assets 0.04M 0.04M 0.00M 0.00M -
Total liab 2.89M 1.85M 0.00M - 0.00M
Total stockholder equity -2.44M -1.14M -0.00M 0.00M 0.31M
Other current liab 0.15M 0.00M 0.00M - 0.00M
Common stock 0.43M 0.26M 0.00M 0.00M 0.06M
Retained earnings -4.93M -3.31M -0.00M -0.00M -0.84M
Other assets - - 0.00M 0.00M -
Cash 0.02M 0.01M 0.00M 0.00M 0.23M
Total current liabilities 2.89M 1.85M 0.00M - 0.00M
Net debt 2.46M 1.65M -0.00M -0.00M -0.23M
Short term debt 2.48M 1.66M - - -
Short long term debt total 2.48M 1.66M - - -
Other stockholder equity 2.47M 2.14M 0.00M 0.00M 1.13M
Total current assets 0.40M 0.63M 0.00M 0.00M 0.31M
Net tangible assets - - -0.13M 0.14M -
Short term investments 0.33M 0.33M - - -
Net receivables - 0.25M - - -
Inventory - - 0.00M 0.00M 0.09M
Accounts payable 0.25M 0.18M 0.00M - -
Accumulated other comprehensive income -0.43M -0.26M 0.00M 0.00M -0.06M
Non currrent assets other 0.00M 0.00M -0.00M -0.00M 0.09M
Non current assets total 0.14M 0.16M 0.00M 0.00M 0.09M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Change to liabilities - - 0.01M -0.00M -
Total cashflows from investing activities 0.16M -0.63M - - -
Net borrowings - - 0.25M 0.25M -
Total cash from financing activities 1.07M 2.30M 0.00M 0.25M 0.09M
Net income -1.63M -2.11M -0.00M -0.00M -0.07M
Change in cash 0.01M -0.24M 0.00M -0.00M -0.59M
Begin period cash flow 0.01M 0.26M 0.00M 0.00M 0.81M
End period cash flow 0.02M 0.01M 0.00M 0.00M 0.23M
Total cash from operating activities -1.22M -1.90M -0.00M -0.00M -0.05M
Depreciation 0.02M 0.02M 0.00M 0.00M 0.01M
Other cashflows from investing activities 0.16M -0.58M - - -
Change to inventory - 0.07M 0.00M 0.00M 0.00M
Other cashflows from financing activities 0.16M -0.63M 0.00M - -
Change to netincome - - -0.00M 0.00M -
Capital expenditures 0.00M 0.05M 0.00M 0.00M 0.00M
Change in working capital 0.07M 0.19M 0.00M 0.00M 0.00M
Other non cash items 0.32M -0.21M 0.00M -0.00M -0.00M
Free cash flow -1.22M -1.95M -0.00M -0.00M -0.05M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
EMGE
Emergent Health Corp
-
-%
0.00 - - 0.36 -
MKKGY
Merck KGaA ADR
-0.68
2.09%
31.83 21.25 14.93 3.10 2.14
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
163.45 24.86 15.11 3.13 1.98
TAK
Takeda Pharmaceutical Co Ltd ADR
0.38
1.77%
21.79 - 10.96 0.01 1.20
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.05 - 10.66 0.01 1.16

Profile*

Emergent Health Corp

Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. was incorporated in 2006 and is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.

10120 Valley Forge Circle, King of Prussia, PA, United States, 19406

484-518-9000

Name Title Year Born
Mr. James W. Zimbler Chief Exec. Officer 1966
Mr. Gregory McCauley Corp. Counsel NA
Mr. Marvin Segel Director & CMO NA
Mr. James W. Zimbler Chief Executive Officer 1961
Mr. Gregory McCauley Corporate Counsel NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…